Detail Information of Epigenetic Regulations
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0126 Transporter Info | ||||
Gene Name | SLC19A1 | ||||
Transporter Name | Folate transporter 1 | ||||
Gene ID | |||||
UniProt ID | |||||
Epigenetic Regulations of This DT (EGR) | |||||
---|---|---|---|---|---|
Methylation |
|||||
Atypical teratoid rhabdoid tumor |
11 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC19A1 in atypical teratoid rhabdoid tumor | [ 1 ] | |||
Location |
5'UTR (cg03721454) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.31E+00 | Statistic Test | p-value: 1.90E-08; Z-score: -1.44E+00 | ||
Methylation in Case |
5.47E-01 (Median) | Methylation in Control | 7.17E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC19A1 in atypical teratoid rhabdoid tumor | [ 1 ] | |||
Location |
5'UTR (cg06731865) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.37E+00 | Statistic Test | p-value: 6.96E-08; Z-score: 1.59E+00 | ||
Methylation in Case |
7.54E-01 (Median) | Methylation in Control | 5.50E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC19A1 in atypical teratoid rhabdoid tumor | [ 1 ] | |||
Location |
5'UTR (cg15725933) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.12E+00 | Statistic Test | p-value: 1.54E-06; Z-score: -1.15E+00 | ||
Methylation in Case |
7.05E-01 (Median) | Methylation in Control | 7.88E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC19A1 in atypical teratoid rhabdoid tumor | [ 1 ] | |||
Location |
5'UTR (cg18035534) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.47E+00 | Statistic Test | p-value: 2.28E-06; Z-score: 1.53E+00 | ||
Methylation in Case |
7.29E-01 (Median) | Methylation in Control | 4.96E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC19A1 in atypical teratoid rhabdoid tumor | [ 1 ] | |||
Location |
5'UTR (cg18353345) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.36E+00 | Statistic Test | p-value: 2.47E-06; Z-score: -1.02E+00 | ||
Methylation in Case |
4.91E-01 (Median) | Methylation in Control | 6.66E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SLC19A1 in atypical teratoid rhabdoid tumor | [ 1 ] | |||
Location |
Body (cg00714531) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.15E+00 | Statistic Test | p-value: 3.45E-05; Z-score: 4.68E-01 | ||
Methylation in Case |
1.91E-01 (Median) | Methylation in Control | 1.66E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 7 |
Methylation of SLC19A1 in atypical teratoid rhabdoid tumor | [ 1 ] | |||
Location |
Body (cg03031182) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.13E+00 | Statistic Test | p-value: 2.49E-04; Z-score: 7.86E-01 | ||
Methylation in Case |
8.68E-01 (Median) | Methylation in Control | 7.68E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 8 |
Methylation of SLC19A1 in atypical teratoid rhabdoid tumor | [ 1 ] | |||
Location |
Body (cg04307902) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -3.32E+00 | Statistic Test | p-value: 6.84E-04; Z-score: -3.54E-01 | ||
Methylation in Case |
2.75E-02 (Median) | Methylation in Control | 9.11E-02 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 9 |
Methylation of SLC19A1 in atypical teratoid rhabdoid tumor | [ 1 ] | |||
Location |
Body (cg07844507) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.02E+00 | Statistic Test | p-value: 5.00E-03; Z-score: 5.35E-02 | ||
Methylation in Case |
1.61E-01 (Median) | Methylation in Control | 1.57E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 10 |
Methylation of SLC19A1 in atypical teratoid rhabdoid tumor | [ 1 ] | |||
Location |
Body (cg07996352) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.19E+00 | Statistic Test | p-value: 5.22E-03; Z-score: -9.30E-01 | ||
Methylation in Case |
2.61E-01 (Median) | Methylation in Control | 3.10E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 11 |
Methylation of SLC19A1 in atypical teratoid rhabdoid tumor | [ 1 ] | |||
Location |
3'UTR (cg22991943) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.31E+00 | Statistic Test | p-value: 7.61E-10; Z-score: -1.65E+00 | ||
Methylation in Case |
5.60E-01 (Median) | Methylation in Control | 7.33E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Bladder cancer |
10 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC19A1 in bladder cancer | [ 2 ] | |||
Location |
5'UTR (cg18035534) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.45E+00 | Statistic Test | p-value: 2.59E-09; Z-score: -1.99E+01 | ||
Methylation in Case |
5.76E-01 (Median) | Methylation in Control | 8.37E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC19A1 in bladder cancer | [ 2 ] | |||
Location |
5'UTR (cg03721454) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.25E+00 | Statistic Test | p-value: 6.77E-04; Z-score: 4.92E+00 | ||
Methylation in Case |
6.57E-01 (Median) | Methylation in Control | 5.28E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC19A1 in bladder cancer | [ 2 ] | |||
Location |
5'UTR (cg06731865) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.08E+00 | Statistic Test | p-value: 6.91E-04; Z-score: -3.04E+00 | ||
Methylation in Case |
7.58E-01 (Median) | Methylation in Control | 8.18E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC19A1 in bladder cancer | [ 2 ] | |||
Location |
TSS1500 (cg17243364) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.28E+00 | Statistic Test | p-value: 1.60E-07; Z-score: -7.42E+00 | ||
Methylation in Case |
1.55E-01 (Median) | Methylation in Control | 1.99E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC19A1 in bladder cancer | [ 2 ] | |||
Location |
TSS200 (cg10119313) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.48E+00 | Statistic Test | p-value: 1.82E-03; Z-score: -2.48E+00 | ||
Methylation in Case |
3.51E-02 (Median) | Methylation in Control | 5.19E-02 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SLC19A1 in bladder cancer | [ 2 ] | |||
Location |
TSS200 (cg11940663) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.33E+00 | Statistic Test | p-value: 3.80E-02; Z-score: -1.06E+00 | ||
Methylation in Case |
3.20E-02 (Median) | Methylation in Control | 4.26E-02 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 7 |
Methylation of SLC19A1 in bladder cancer | [ 2 ] | |||
Location |
Body (cg17803589) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.80E+00 | Statistic Test | p-value: 1.34E-10; Z-score: -1.14E+01 | ||
Methylation in Case |
3.99E-01 (Median) | Methylation in Control | 7.18E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 8 |
Methylation of SLC19A1 in bladder cancer | [ 2 ] | |||
Location |
Body (cg03031182) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.21E+00 | Statistic Test | p-value: 1.88E-06; Z-score: -6.58E+00 | ||
Methylation in Case |
6.59E-01 (Median) | Methylation in Control | 7.97E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 9 |
Methylation of SLC19A1 in bladder cancer | [ 2 ] | |||
Location |
Body (cg07844507) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.14E+00 | Statistic Test | p-value: 4.36E-06; Z-score: -5.09E+00 | ||
Methylation in Case |
7.15E-01 (Median) | Methylation in Control | 8.17E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 10 |
Methylation of SLC19A1 in bladder cancer | [ 2 ] | |||
Location |
Body (cg19074198) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.31E+00 | Statistic Test | p-value: 2.48E-05; Z-score: 4.92E+00 | ||
Methylation in Case |
7.93E-01 (Median) | Methylation in Control | 6.05E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Breast cancer |
11 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC19A1 in breast cancer | [ 3 ] | |||
Location |
5'UTR (cg06731865) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.04E+00 | Statistic Test | p-value: 1.03E-04; Z-score: -9.42E-01 | ||
Methylation in Case |
8.03E-01 (Median) | Methylation in Control | 8.36E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC19A1 in breast cancer | [ 3 ] | |||
Location |
5'UTR (cg03721454) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.14E+00 | Statistic Test | p-value: 9.75E-04; Z-score: 1.12E+00 | ||
Methylation in Case |
4.86E-01 (Median) | Methylation in Control | 4.27E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC19A1 in breast cancer | [ 3 ] | |||
Location |
5'UTR (cg18035534) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.03E+00 | Statistic Test | p-value: 9.93E-03; Z-score: -6.78E-01 | ||
Methylation in Case |
8.57E-01 (Median) | Methylation in Control | 8.86E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC19A1 in breast cancer | [ 3 ] | |||
Location |
5'UTR (cg18353345) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.06E+00 | Statistic Test | p-value: 2.20E-02; Z-score: -3.29E-01 | ||
Methylation in Case |
7.76E-02 (Median) | Methylation in Control | 8.25E-02 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC19A1 in breast cancer | [ 3 ] | |||
Location |
TSS1500 (cg07658590) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.42E+00 | Statistic Test | p-value: 1.35E-18; Z-score: 3.39E+00 | ||
Methylation in Case |
5.86E-01 (Median) | Methylation in Control | 4.14E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SLC19A1 in breast cancer | [ 3 ] | |||
Location |
TSS1500 (cg17243364) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.13E+00 | Statistic Test | p-value: 2.85E-03; Z-score: -9.74E-01 | ||
Methylation in Case |
1.62E-01 (Median) | Methylation in Control | 1.84E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 7 |
Methylation of SLC19A1 in breast cancer | [ 3 ] | |||
Location |
TSS200 (cg18108695) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.12E+00 | Statistic Test | p-value: 4.89E-02; Z-score: 2.49E-01 | ||
Methylation in Case |
5.64E-02 (Median) | Methylation in Control | 5.02E-02 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 8 |
Methylation of SLC19A1 in breast cancer | [ 3 ] | |||
Location |
Body (cg27368243) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.15E+00 | Statistic Test | p-value: 1.49E-03; Z-score: -1.42E+00 | ||
Methylation in Case |
4.54E-01 (Median) | Methylation in Control | 5.23E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 9 |
Methylation of SLC19A1 in breast cancer | [ 3 ] | |||
Location |
Body (cg07844507) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.03E+00 | Statistic Test | p-value: 1.30E-02; Z-score: 3.08E-01 | ||
Methylation in Case |
7.83E-01 (Median) | Methylation in Control | 7.62E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 10 |
Methylation of SLC19A1 in breast cancer | [ 3 ] | |||
Location |
Body (cg04307902) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.03E+00 | Statistic Test | p-value: 2.14E-02; Z-score: -6.75E-01 | ||
Methylation in Case |
8.60E-01 (Median) | Methylation in Control | 8.90E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 11 |
Methylation of SLC19A1 in breast cancer | [ 3 ] | |||
Location |
3'UTR (cg22991943) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.14E+00 | Statistic Test | p-value: 9.53E-08; Z-score: -1.87E+00 | ||
Methylation in Case |
6.31E-01 (Median) | Methylation in Control | 7.21E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Renal cell carcinoma |
8 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC19A1 in clear cell renal cell carcinoma | [ 4 ] | |||
Location |
5'UTR (cg18353345) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -3.29E+00 | Statistic Test | p-value: 8.06E-10; Z-score: -2.39E+00 | ||
Methylation in Case |
6.73E-02 (Median) | Methylation in Control | 2.21E-01 (Median) | ||
Studied Phenotype |
Renal cell carcinoma [ ICD-11: 2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC19A1 in clear cell renal cell carcinoma | [ 4 ] | |||
Location |
5'UTR (cg03721454) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.33E+00 | Statistic Test | p-value: 6.99E-07; Z-score: 3.19E+00 | ||
Methylation in Case |
7.00E-01 (Median) | Methylation in Control | 5.27E-01 (Median) | ||
Studied Phenotype |
Renal cell carcinoma [ ICD-11: 2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC19A1 in clear cell renal cell carcinoma | [ 4 ] | |||
Location |
5'UTR (cg06731865) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.04E+00 | Statistic Test | p-value: 1.04E-06; Z-score: -2.54E+00 | ||
Methylation in Case |
9.02E-01 (Median) | Methylation in Control | 9.37E-01 (Median) | ||
Studied Phenotype |
Renal cell carcinoma [ ICD-11: 2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC19A1 in clear cell renal cell carcinoma | [ 4 ] | |||
Location |
TSS1500 (cg21279603) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.08E+00 | Statistic Test | p-value: 2.81E-08; Z-score: -1.58E+00 | ||
Methylation in Case |
8.23E-01 (Median) | Methylation in Control | 8.88E-01 (Median) | ||
Studied Phenotype |
Renal cell carcinoma [ ICD-11: 2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC19A1 in clear cell renal cell carcinoma | [ 4 ] | |||
Location |
Body (cg27368243) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.14E+00 | Statistic Test | p-value: 1.12E-06; Z-score: -1.51E+00 | ||
Methylation in Case |
7.14E-01 (Median) | Methylation in Control | 8.16E-01 (Median) | ||
Studied Phenotype |
Renal cell carcinoma [ ICD-11: 2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SLC19A1 in clear cell renal cell carcinoma | [ 4 ] | |||
Location |
Body (cg07844507) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.02E+00 | Statistic Test | p-value: 3.90E-05; Z-score: -1.38E+00 | ||
Methylation in Case |
9.40E-01 (Median) | Methylation in Control | 9.56E-01 (Median) | ||
Studied Phenotype |
Renal cell carcinoma [ ICD-11: 2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 7 |
Methylation of SLC19A1 in clear cell renal cell carcinoma | [ 4 ] | |||
Location |
Body (cg03031182) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.23E+00 | Statistic Test | p-value: 2.96E-03; Z-score: 2.74E+00 | ||
Methylation in Case |
8.74E-01 (Median) | Methylation in Control | 7.09E-01 (Median) | ||
Studied Phenotype |
Renal cell carcinoma [ ICD-11: 2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 8 |
Methylation of SLC19A1 in clear cell renal cell carcinoma | [ 4 ] | |||
Location |
Body (cg16071082) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.00E+00 | Statistic Test | p-value: 1.17E-02; Z-score: -4.74E-01 | ||
Methylation in Case |
9.70E-01 (Median) | Methylation in Control | 9.73E-01 (Median) | ||
Studied Phenotype |
Renal cell carcinoma [ ICD-11: 2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Colon cancer |
8 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC19A1 in colon adenocarcinoma | [ 5 ] | |||
Location |
5'UTR (cg14393466) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.10E+00 | Statistic Test | p-value: 1.75E-03; Z-score: -1.86E+00 | ||
Methylation in Case |
6.84E-01 (Median) | Methylation in Control | 7.55E-01 (Median) | ||
Studied Phenotype |
Colon cancer [ ICD-11: 2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC19A1 in colon adenocarcinoma | [ 5 ] | |||
Location |
TSS1500 (cg04592728) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.61E+00 | Statistic Test | p-value: 1.34E-06; Z-score: 3.68E+00 | ||
Methylation in Case |
5.61E-01 (Median) | Methylation in Control | 3.48E-01 (Median) | ||
Studied Phenotype |
Colon cancer [ ICD-11: 2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC19A1 in colon adenocarcinoma | [ 5 ] | |||
Location |
TSS200 (cg03929977) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 2.24E+00 | Statistic Test | p-value: 5.60E-08; Z-score: 3.88E+00 | ||
Methylation in Case |
5.03E-01 (Median) | Methylation in Control | 2.25E-01 (Median) | ||
Studied Phenotype |
Colon cancer [ ICD-11: 2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC19A1 in colon adenocarcinoma | [ 5 ] | |||
Location |
TSS200 (cg25811526) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.36E+00 | Statistic Test | p-value: 1.09E-06; Z-score: -3.93E+00 | ||
Methylation in Case |
3.88E-01 (Median) | Methylation in Control | 5.29E-01 (Median) | ||
Studied Phenotype |
Colon cancer [ ICD-11: 2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC19A1 in colon adenocarcinoma | [ 5 ] | |||
Location |
1stExon (cg05063104) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.22E+00 | Statistic Test | p-value: 4.87E-04; Z-score: 1.98E+00 | ||
Methylation in Case |
4.92E-01 (Median) | Methylation in Control | 4.03E-01 (Median) | ||
Studied Phenotype |
Colon cancer [ ICD-11: 2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SLC19A1 in colon adenocarcinoma | [ 5 ] | |||
Location |
Body (cg12461092) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.45E+00 | Statistic Test | p-value: 2.68E-07; Z-score: -5.63E+00 | ||
Methylation in Case |
4.57E-01 (Median) | Methylation in Control | 6.64E-01 (Median) | ||
Studied Phenotype |
Colon cancer [ ICD-11: 2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 7 |
Methylation of SLC19A1 in colon adenocarcinoma | [ 5 ] | |||
Location |
Body (cg25822376) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.32E+00 | Statistic Test | p-value: 1.36E-06; Z-score: -3.08E+00 | ||
Methylation in Case |
5.36E-01 (Median) | Methylation in Control | 7.08E-01 (Median) | ||
Studied Phenotype |
Colon cancer [ ICD-11: 2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 8 |
Methylation of SLC19A1 in colon adenocarcinoma | [ 5 ] | |||
Location |
Body (cg04470085) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.14E+00 | Statistic Test | p-value: 1.84E-05; Z-score: -5.56E+00 | ||
Methylation in Case |
7.25E-01 (Median) | Methylation in Control | 8.28E-01 (Median) | ||
Studied Phenotype |
Colon cancer [ ICD-11: 2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Colorectal cancer |
13 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC19A1 in colorectal cancer | [ 6 ] | |||
Location |
5'UTR (cg06731865) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.02E+00 | Statistic Test | p-value: 5.12E-08; Z-score: -1.78E+00 | ||
Methylation in Case |
8.95E-01 (Median) | Methylation in Control | 9.16E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC19A1 in colorectal cancer | [ 6 ] | |||
Location |
5'UTR (cg15725933) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.14E+00 | Statistic Test | p-value: 2.59E-02; Z-score: 6.30E-01 | ||
Methylation in Case |
3.78E-02 (Median) | Methylation in Control | 3.31E-02 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC19A1 in colorectal cancer | [ 6 ] | |||
Location |
TSS1500 (cg17243364) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.29E+00 | Statistic Test | p-value: 5.41E-07; Z-score: 1.62E+00 | ||
Methylation in Case |
2.64E-01 (Median) | Methylation in Control | 2.05E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC19A1 in colorectal cancer | [ 6 ] | |||
Location |
TSS1500 (cg21279603) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.05E+00 | Statistic Test | p-value: 1.16E-06; Z-score: -1.71E+00 | ||
Methylation in Case |
8.48E-01 (Median) | Methylation in Control | 8.94E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC19A1 in colorectal cancer | [ 6 ] | |||
Location |
TSS1500 (cg07658590) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.09E+00 | Statistic Test | p-value: 1.12E-03; Z-score: -1.01E+00 | ||
Methylation in Case |
7.34E-01 (Median) | Methylation in Control | 7.98E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SLC19A1 in colorectal cancer | [ 6 ] | |||
Location |
TSS200 (cg18108695) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.34E+00 | Statistic Test | p-value: 1.32E-04; Z-score: 1.29E+00 | ||
Methylation in Case |
3.75E-02 (Median) | Methylation in Control | 2.81E-02 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 7 |
Methylation of SLC19A1 in colorectal cancer | [ 6 ] | |||
Location |
TSS200 (cg10119313) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.12E+00 | Statistic Test | p-value: 3.80E-03; Z-score: 4.29E-01 | ||
Methylation in Case |
2.58E-02 (Median) | Methylation in Control | 2.30E-02 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 8 |
Methylation of SLC19A1 in colorectal cancer | [ 6 ] | |||
Location |
Body (cg19074198) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.20E+00 | Statistic Test | p-value: 2.17E-05; Z-score: 1.42E+00 | ||
Methylation in Case |
8.68E-01 (Median) | Methylation in Control | 7.24E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 9 |
Methylation of SLC19A1 in colorectal cancer | [ 6 ] | |||
Location |
Body (cg07844507) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.02E+00 | Statistic Test | p-value: 1.09E-04; Z-score: -9.80E-01 | ||
Methylation in Case |
9.16E-01 (Median) | Methylation in Control | 9.32E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 10 |
Methylation of SLC19A1 in colorectal cancer | [ 6 ] | |||
Location |
Body (cg27368243) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.05E+00 | Statistic Test | p-value: 3.31E-02; Z-score: -4.99E-01 | ||
Methylation in Case |
7.66E-01 (Median) | Methylation in Control | 8.07E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 11 |
Methylation of SLC19A1 in colorectal cancer | [ 6 ] | |||
Location |
Body (cg04307902) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.00E+00 | Statistic Test | p-value: 4.99E-02; Z-score: -1.63E-01 | ||
Methylation in Case |
9.41E-01 (Median) | Methylation in Control | 9.43E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 12 |
Methylation of SLC19A1 in colorectal cancer | [ 6 ] | |||
Location |
3'UTR (cg22991943) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.00E+00 | Statistic Test | p-value: 1.05E-02; Z-score: -3.37E-01 | ||
Methylation in Case |
9.11E-01 (Median) | Methylation in Control | 9.15E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 13 |
Hypermethylation of SLC19A1 in colorectal cancer | [ 18 ] | |||
Location |
Promoter | ||||
Epigenetic Type |
Methylation | Experiment Method | Methylation-specific PCR | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Frequency |
33 (78%) out of the 42 studied tumor samples | ||||
Experimental Material |
Patient tissue samples | ||||
Additional Notes |
SLC19A1 promoter Hypermethylation contribute to the occurrence and metastasis of CRC. | ||||
Depression |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC19A1 in depression | [ 7 ] | |||
Location |
5'UTR (cg18353345) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.07E+00 | Statistic Test | p-value: 1.60E-02; Z-score: -6.74E-01 | ||
Methylation in Case |
7.15E-02 (Median) | Methylation in Control | 7.68E-02 (Median) | ||
Studied Phenotype |
Depression [ ICD-11: 6A8Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Hepatocellular carcinoma |
12 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC19A1 in hepatocellular carcinoma | [ 8 ] | |||
Location |
5'UTR (cg03721454) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.01E+00 | Statistic Test | p-value: 4.30E-02; Z-score: -1.35E-01 | ||
Methylation in Case |
6.99E-01 (Median) | Methylation in Control | 7.05E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC19A1 in hepatocellular carcinoma | [ 8 ] | |||
Location |
TSS200 (cg02203420) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.65E+00 | Statistic Test | p-value: 3.96E-20; Z-score: -6.83E+00 | ||
Methylation in Case |
4.66E-01 (Median) | Methylation in Control | 7.70E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC19A1 in hepatocellular carcinoma | [ 8 ] | |||
Location |
TSS200 (cg22149516) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 2.55E+00 | Statistic Test | p-value: 6.67E-10; Z-score: 5.60E+00 | ||
Methylation in Case |
2.76E-01 (Median) | Methylation in Control | 1.08E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC19A1 in hepatocellular carcinoma | [ 8 ] | |||
Location |
Body (cg23462788) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.80E+00 | Statistic Test | p-value: 1.99E-22; Z-score: -9.81E+00 | ||
Methylation in Case |
4.52E-01 (Median) | Methylation in Control | 8.14E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC19A1 in hepatocellular carcinoma | [ 8 ] | |||
Location |
Body (cg02641517) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.85E+00 | Statistic Test | p-value: 3.04E-17; Z-score: -4.02E+00 | ||
Methylation in Case |
3.68E-01 (Median) | Methylation in Control | 6.82E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SLC19A1 in hepatocellular carcinoma | [ 8 ] | |||
Location |
Body (cg07806361) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.41E+00 | Statistic Test | p-value: 2.47E-14; Z-score: -4.85E+00 | ||
Methylation in Case |
5.53E-01 (Median) | Methylation in Control | 7.79E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 7 |
Methylation of SLC19A1 in hepatocellular carcinoma | [ 8 ] | |||
Location |
Body (cg14310831) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.28E+00 | Statistic Test | p-value: 4.06E-11; Z-score: -1.72E+00 | ||
Methylation in Case |
5.99E-01 (Median) | Methylation in Control | 7.68E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 8 |
Methylation of SLC19A1 in hepatocellular carcinoma | [ 8 ] | |||
Location |
Body (cg27368243) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.13E+00 | Statistic Test | p-value: 8.89E-05; Z-score: 7.13E-01 | ||
Methylation in Case |
5.38E-01 (Median) | Methylation in Control | 4.75E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 9 |
Methylation of SLC19A1 in hepatocellular carcinoma | [ 8 ] | |||
Location |
Body (cg03031182) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.00E+00 | Statistic Test | p-value: 5.16E-03; Z-score: -2.24E-01 | ||
Methylation in Case |
8.53E-01 (Median) | Methylation in Control | 8.56E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 10 |
Methylation of SLC19A1 in hepatocellular carcinoma | [ 8 ] | |||
Location |
Body (cg17803589) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.03E+00 | Statistic Test | p-value: 1.37E-02; Z-score: 4.55E-01 | ||
Methylation in Case |
8.12E-01 (Median) | Methylation in Control | 7.89E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 11 |
Methylation of SLC19A1 in hepatocellular carcinoma | [ 8 ] | |||
Location |
Body (cg07844507) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.01E+00 | Statistic Test | p-value: 1.38E-02; Z-score: 4.87E-01 | ||
Methylation in Case |
8.34E-01 (Median) | Methylation in Control | 8.22E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 12 |
Methylation of SLC19A1 in hepatocellular carcinoma | [ 8 ] | |||
Location |
Body (cg00714531) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.04E+00 | Statistic Test | p-value: 3.35E-02; Z-score: 2.10E-01 | ||
Methylation in Case |
8.49E-01 (Median) | Methylation in Control | 8.19E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
HIV infection |
8 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC19A1 in HIV infection | [ 9 ] | |||
Location |
5'UTR (cg06731865) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.18E+00 | Statistic Test | p-value: 1.31E-10; Z-score: 3.30E+00 | ||
Methylation in Case |
7.70E-01 (Median) | Methylation in Control | 6.54E-01 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC19A1 in HIV infection | [ 9 ] | |||
Location |
TSS1500 (cg21279603) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.17E+00 | Statistic Test | p-value: 4.62E-12; Z-score: 2.36E+00 | ||
Methylation in Case |
7.31E-01 (Median) | Methylation in Control | 6.26E-01 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC19A1 in HIV infection | [ 9 ] | |||
Location |
TSS1500 (cg07658590) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.35E+00 | Statistic Test | p-value: 2.73E-11; Z-score: 2.94E+00 | ||
Methylation in Case |
6.06E-01 (Median) | Methylation in Control | 4.49E-01 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC19A1 in HIV infection | [ 9 ] | |||
Location |
TSS1500 (cg17243364) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.22E+00 | Statistic Test | p-value: 8.53E-07; Z-score: 1.50E+00 | ||
Methylation in Case |
2.11E-01 (Median) | Methylation in Control | 1.73E-01 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC19A1 in HIV infection | [ 9 ] | |||
Location |
Body (cg00714531) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.05E+00 | Statistic Test | p-value: 4.00E-08; Z-score: 1.37E+00 | ||
Methylation in Case |
9.07E-01 (Median) | Methylation in Control | 8.60E-01 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SLC19A1 in HIV infection | [ 9 ] | |||
Location |
Body (cg07844507) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.07E+00 | Statistic Test | p-value: 1.33E-07; Z-score: 1.62E+00 | ||
Methylation in Case |
7.97E-01 (Median) | Methylation in Control | 7.45E-01 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 7 |
Methylation of SLC19A1 in HIV infection | [ 9 ] | |||
Location |
Body (cg27368243) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.29E+00 | Statistic Test | p-value: 1.95E-05; Z-score: 2.12E+00 | ||
Methylation in Case |
3.77E-01 (Median) | Methylation in Control | 2.92E-01 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 8 |
Methylation of SLC19A1 in HIV infection | [ 9 ] | |||
Location |
Body (cg19074198) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.01E+00 | Statistic Test | p-value: 1.43E-03; Z-score: 4.92E-01 | ||
Methylation in Case |
8.74E-01 (Median) | Methylation in Control | 8.63E-01 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Lung adenocarcinoma |
6 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC19A1 in lung adenocarcinoma | [ 10 ] | |||
Location |
5'UTR (cg18353345) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.36E+00 | Statistic Test | p-value: 2.41E-03; Z-score: -1.50E+00 | ||
Methylation in Case |
1.72E-01 (Median) | Methylation in Control | 2.34E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma [ ICD-11: 2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC19A1 in lung adenocarcinoma | [ 10 ] | |||
Location |
5'UTR (cg03721454) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.19E+00 | Statistic Test | p-value: 1.32E-02; Z-score: 1.48E+00 | ||
Methylation in Case |
7.55E-01 (Median) | Methylation in Control | 6.37E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma [ ICD-11: 2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC19A1 in lung adenocarcinoma | [ 10 ] | |||
Location |
TSS1500 (cg07658590) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.21E+00 | Statistic Test | p-value: 1.61E-03; Z-score: 4.09E+00 | ||
Methylation in Case |
6.41E-01 (Median) | Methylation in Control | 5.30E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma [ ICD-11: 2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC19A1 in lung adenocarcinoma | [ 10 ] | |||
Location |
Body (cg19074198) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.11E+00 | Statistic Test | p-value: 5.63E-03; Z-score: 2.00E+00 | ||
Methylation in Case |
8.19E-01 (Median) | Methylation in Control | 7.39E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma [ ICD-11: 2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC19A1 in lung adenocarcinoma | [ 10 ] | |||
Location |
Body (cg00714531) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.04E+00 | Statistic Test | p-value: 3.31E-02; Z-score: 1.13E+00 | ||
Methylation in Case |
9.06E-01 (Median) | Methylation in Control | 8.75E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma [ ICD-11: 2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SLC19A1 in lung adenocarcinoma | [ 10 ] | |||
Location |
Body (cg27368243) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.07E+00 | Statistic Test | p-value: 4.55E-02; Z-score: -1.14E+00 | ||
Methylation in Case |
5.94E-01 (Median) | Methylation in Control | 6.36E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma [ ICD-11: 2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Panic disorder |
2 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC19A1 in panic disorder | [ 11 ] | |||
Location |
5'UTR (cg15725933) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -9.90E-01 | Statistic Test | p-value: 4.80E-02; Z-score: -3.03E-01 | ||
Methylation in Case |
-5.53E+00 (Median) | Methylation in Control | -5.47E+00 (Median) | ||
Studied Phenotype |
Panic disorder [ ICD-11: 6B01] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC19A1 in panic disorder | [ 11 ] | |||
Location |
TSS1500 (cg07658590) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -8.04E-01 | Statistic Test | p-value: 5.68E-03; Z-score: -5.32E-01 | ||
Methylation in Case |
-9.11E-01 (Median) | Methylation in Control | -7.33E-01 (Median) | ||
Studied Phenotype |
Panic disorder [ ICD-11: 6B01] | ||||
Experimental Material |
Patient tissue samples | ||||
Papillary thyroid cancer |
12 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC19A1 in papillary thyroid cancer | [ 12 ] | |||
Location |
5'UTR (cg03721454) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.12E+00 | Statistic Test | p-value: 2.19E-07; Z-score: 1.64E+00 | ||
Methylation in Case |
7.74E-01 (Median) | Methylation in Control | 6.90E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC19A1 in papillary thyroid cancer | [ 12 ] | |||
Location |
5'UTR (cg18353345) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.31E+00 | Statistic Test | p-value: 2.08E-05; Z-score: -9.67E-01 | ||
Methylation in Case |
1.25E-01 (Median) | Methylation in Control | 1.63E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC19A1 in papillary thyroid cancer | [ 12 ] | |||
Location |
5'UTR (cg06731865) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.01E+00 | Statistic Test | p-value: 7.26E-03; Z-score: -6.25E-01 | ||
Methylation in Case |
9.12E-01 (Median) | Methylation in Control | 9.22E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC19A1 in papillary thyroid cancer | [ 12 ] | |||
Location |
5'UTR (cg15725933) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.07E+00 | Statistic Test | p-value: 2.10E-02; Z-score: -5.95E-01 | ||
Methylation in Case |
7.70E-02 (Median) | Methylation in Control | 8.22E-02 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC19A1 in papillary thyroid cancer | [ 12 ] | |||
Location |
TSS1500 (cg17243364) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.14E+00 | Statistic Test | p-value: 6.01E-06; Z-score: -8.12E-01 | ||
Methylation in Case |
1.61E-01 (Median) | Methylation in Control | 1.83E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SLC19A1 in papillary thyroid cancer | [ 12 ] | |||
Location |
TSS1500 (cg21279603) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.01E+00 | Statistic Test | p-value: 3.15E-03; Z-score: -4.04E-01 | ||
Methylation in Case |
8.04E-01 (Median) | Methylation in Control | 8.15E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 7 |
Methylation of SLC19A1 in papillary thyroid cancer | [ 12 ] | |||
Location |
Body (cg00714531) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.01E+00 | Statistic Test | p-value: 3.74E-06; Z-score: -1.06E+00 | ||
Methylation in Case |
9.46E-01 (Median) | Methylation in Control | 9.57E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 8 |
Methylation of SLC19A1 in papillary thyroid cancer | [ 12 ] | |||
Location |
Body (cg25310447) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.01E+00 | Statistic Test | p-value: 1.14E-03; Z-score: -7.98E-01 | ||
Methylation in Case |
9.34E-01 (Median) | Methylation in Control | 9.41E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 9 |
Methylation of SLC19A1 in papillary thyroid cancer | [ 12 ] | |||
Location |
Body (cg07996352) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.01E+00 | Statistic Test | p-value: 5.00E-03; Z-score: -4.16E-01 | ||
Methylation in Case |
9.12E-01 (Median) | Methylation in Control | 9.18E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 10 |
Methylation of SLC19A1 in papillary thyroid cancer | [ 12 ] | |||
Location |
Body (cg27368243) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.02E+00 | Statistic Test | p-value: 1.58E-02; Z-score: -2.47E-01 | ||
Methylation in Case |
7.56E-01 (Median) | Methylation in Control | 7.72E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 11 |
Methylation of SLC19A1 in papillary thyroid cancer | [ 12 ] | |||
Location |
Body (cg07844507) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.00E+00 | Statistic Test | p-value: 1.60E-02; Z-score: -1.64E-01 | ||
Methylation in Case |
8.98E-01 (Median) | Methylation in Control | 9.01E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 12 |
Methylation of SLC19A1 in papillary thyroid cancer | [ 12 ] | |||
Location |
3'UTR (cg22991943) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.02E+00 | Statistic Test | p-value: 1.46E-02; Z-score: -6.77E-01 | ||
Methylation in Case |
8.55E-01 (Median) | Methylation in Control | 8.69E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Pancretic ductal adenocarcinoma |
10 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC19A1 in pancretic ductal adenocarcinoma | [ 13 ] | |||
Location |
TSS1500 (cg06517489) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.02E+00 | Statistic Test | p-value: 8.14E-07; Z-score: 7.60E-02 | ||
Methylation in Case |
1.19E-01 (Median) | Methylation in Control | 1.17E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC19A1 in pancretic ductal adenocarcinoma | [ 13 ] | |||
Location |
TSS1500 (cg06746492) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.01E+00 | Statistic Test | p-value: 1.10E-04; Z-score: -3.24E-01 | ||
Methylation in Case |
8.21E-01 (Median) | Methylation in Control | 8.31E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC19A1 in pancretic ductal adenocarcinoma | [ 13 ] | |||
Location |
TSS1500 (cg04690729) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.00E+00 | Statistic Test | p-value: 2.44E-02; Z-score: -8.26E-03 | ||
Methylation in Case |
7.89E-01 (Median) | Methylation in Control | 7.89E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC19A1 in pancretic ductal adenocarcinoma | [ 13 ] | |||
Location |
1stExon (cg14930075) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 5.55E+00 | Statistic Test | p-value: 5.14E-29; Z-score: 5.42E+00 | ||
Methylation in Case |
4.37E-01 (Median) | Methylation in Control | 7.88E-02 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC19A1 in pancretic ductal adenocarcinoma | [ 13 ] | |||
Location |
1stExon (cg07726085) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.10E+00 | Statistic Test | p-value: 5.99E-05; Z-score: 1.31E+00 | ||
Methylation in Case |
8.06E-01 (Median) | Methylation in Control | 7.32E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SLC19A1 in pancretic ductal adenocarcinoma | [ 13 ] | |||
Location |
Body (cg23867721) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.10E+00 | Statistic Test | p-value: 3.67E-04; Z-score: 1.34E+00 | ||
Methylation in Case |
6.51E-01 (Median) | Methylation in Control | 5.94E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 7 |
Methylation of SLC19A1 in pancretic ductal adenocarcinoma | [ 13 ] | |||
Location |
Body (cg01554951) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.01E+00 | Statistic Test | p-value: 2.03E-03; Z-score: 8.53E-01 | ||
Methylation in Case |
8.85E-01 (Median) | Methylation in Control | 8.72E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 8 |
Methylation of SLC19A1 in pancretic ductal adenocarcinoma | [ 13 ] | |||
Location |
Body (cg21388745) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.05E+00 | Statistic Test | p-value: 3.03E-03; Z-score: 9.69E-01 | ||
Methylation in Case |
8.56E-01 (Median) | Methylation in Control | 8.15E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 9 |
Methylation of SLC19A1 in pancretic ductal adenocarcinoma | [ 13 ] | |||
Location |
Body (cg14315842) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.04E+00 | Statistic Test | p-value: 7.03E-03; Z-score: 6.27E-01 | ||
Methylation in Case |
8.26E-01 (Median) | Methylation in Control | 7.93E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 10 |
Methylation of SLC19A1 in pancretic ductal adenocarcinoma | [ 13 ] | |||
Location |
3'UTR (cg06535968) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.02E+00 | Statistic Test | p-value: 7.57E-03; Z-score: -3.58E-01 | ||
Methylation in Case |
7.86E-01 (Median) | Methylation in Control | 8.02E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Celiac disease |
2 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC19A1 in celiac disease | [ 14 ] | |||
Location |
Body (cg19074198) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.29E+00 | Statistic Test | p-value: 3.82E-03; Z-score: 1.09E+00 | ||
Methylation in Case |
8.21E-01 (Median) | Methylation in Control | 6.35E-01 (Median) | ||
Studied Phenotype |
Celiac disease [ ICD-11: DA95] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC19A1 in celiac disease | [ 14 ] | |||
Location |
Body (cg27368243) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.46E+00 | Statistic Test | p-value: 4.74E-03; Z-score: -1.24E+00 | ||
Methylation in Case |
4.74E-01 (Median) | Methylation in Control | 6.94E-01 (Median) | ||
Studied Phenotype |
Celiac disease [ ICD-11: DA95] | ||||
Experimental Material |
Patient tissue samples | ||||
Prostate cancer |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC19A1 in prostate cancer | [ 15 ] | |||
Location |
Body (cg26961166) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.79E+00 | Statistic Test | p-value: 5.02E-03; Z-score: -1.67E+01 | ||
Methylation in Case |
2.57E-01 (Median) | Methylation in Control | 4.59E-01 (Median) | ||
Studied Phenotype |
Prostate cancer [ ICD-11: 2C82] | ||||
Experimental Material |
Patient tissue samples | ||||
Systemic lupus erythematosus |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC19A1 in systemic lupus erythematosus | [ 16 ] | |||
Location |
Body (cg07996352) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.00E+00 | Statistic Test | p-value: 4.71E-02; Z-score: -2.27E-01 | ||
Methylation in Case |
9.06E-01 (Median) | Methylation in Control | 9.10E-01 (Median) | ||
Studied Phenotype |
Systemic lupus erythematosus [ ICD-11: 4A40.0] | ||||
Experimental Material |
Patient tissue samples | ||||
microRNA |
|||||
B-cell acute lymphoblastic leukemia |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
miR-595 downregulates SLC19A1 in B-cell acute lymphoblastic leukemia | [ 17 ] | |||
Epigenetic Type |
microRNA | Experiment Method | Microarray | ||
Related Molecular Changes |
Down regulation of SLC19A1 | Experiment Method | Microarrays | ||
miRNA Stemloop ID |
miR-595 | miRNA Mature ID | miR-595 | ||
miRNA Sequence |
GAAGUGUGCCGUGGUGUGUCU | ||||
miRNA Target Type |
Direct | ||||
Studied Phenotype |
B-cell acute lymphoblastic leukemia [ ICD-11: 2A82] | ||||
Experimental Material |
Patient tissue samples | ||||
Additional Notes |
SNPs in miR-595 that might affect SLC19A1 MTX transport gene regulation and could affect MTX levels in patients with pediatric B-cell ALL. | ||||
Unclear Phenotype |
9 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
miR-125b directly targets SLC19A1 | [ 19 ] | |||
Epigenetic Type |
microRNA | Experiment Method | CLASH | ||
miRNA Stemloop ID |
miR-125b | miRNA Mature ID | miR-125b-5p | ||
miRNA Sequence |
UCCCUGAGACCCUAACUUGUGA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon 2 |
miR-16 directly targets SLC19A1 | [ 19 ] | |||
Epigenetic Type |
microRNA | Experiment Method | CLASH | ||
miRNA Stemloop ID |
miR-16 | miRNA Mature ID | miR-16-5p | ||
miRNA Sequence |
UAGCAGCACGUAAAUAUUGGCG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon 3 |
miR-3613 directly targets SLC19A1 | [ 20 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-3613 | miRNA Mature ID | miR-3613-3p | ||
miRNA Sequence |
ACAAAAAAAAAAGCCCAACCCUUC | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 4 |
miR-4422 directly targets SLC19A1 | [ 20 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-4422 | miRNA Mature ID | miR-4422 | ||
miRNA Sequence |
AAAAGCAUCAGGAAGUACCCA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 5 |
miR-4668 directly targets SLC19A1 | [ 20 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-4668 | miRNA Mature ID | miR-4668-5p | ||
miRNA Sequence |
AGGGAAAAAAAAAAGGAUUUGUC | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 6 |
miR-484 directly targets SLC19A1 | [ 19 ] | |||
Epigenetic Type |
microRNA | Experiment Method | CLASH | ||
miRNA Stemloop ID |
miR-484 | miRNA Mature ID | miR-484 | ||
miRNA Sequence |
UCAGGCUCAGUCCCCUCCCGAU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon 7 |
miR-548e directly targets SLC19A1 | [ 20 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-548e | miRNA Mature ID | miR-548e-5p | ||
miRNA Sequence |
CAAAAGCAAUCGCGGUUUUUGC | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 8 |
miR-607 directly targets SLC19A1 | [ 20 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-607 | miRNA Mature ID | miR-607 | ||
miRNA Sequence |
GUUCAAAUCCAGAUCUAUAAC | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 9 |
miR-93 directly targets SLC19A1 | [ 19 ] | |||
Epigenetic Type |
microRNA | Experiment Method | CLASH | ||
miRNA Stemloop ID |
miR-93 | miRNA Mature ID | miR-93-5p | ||
miRNA Sequence |
CAAAGUGCUGUUCGUGCAGGUAG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.